Fulltext

Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models

Wu DB 1 , Chaiyakunapruk N 1 , Pratoomsoot C 2 , Lee KK 3 , Chong HY 1 , Nelson RE 4 Show all authors , Smith PF 5 , Kirkpatrick C 6 , Kamal MA 7 , Nieforth K 5 , Dall G 5 , Toovey S 8 , Kong DC 6 , Kamauu A 9 , Rayner C 5

Affiliations 

  • 1 Monash University Malaysia, Selangor, Malaysia
  • 2 Naresuan University, Muang, Thailand
  • 3 Monash University, Kuala Lumpur, Malaysia
  • 4 University of Utah, Salt Lake City, UT, USA
  • 5 d3 Medicine Limited, Parsippany, NJ, USA
  • 6 Monash University, Parkville, Australia
  • 7 Hoffmann La-Roche, New York, NY, USA
  • 8 Pegasus Research, Basel, Switzerland
  • 9 Anolinx, LLC, Salt Lake City, UT, USA
Value Health, 2014 Nov;17(7):A807.
PMID: 27203045 DOI: 10.1016/j.jval.2014.08.527

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications